Vascular endothelium summary statement II: Cardiovascular disease prevention and control

George A. Mensah, Una S. Ryan, W. Craig Hooper, Michael M. Engelgau, Allan D. Callow, Kakota Gaston Kapuku, Alberto Mantovani

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The prevention and control of cardiovascular disease (CVD), principally ischemic heart disease and stroke, are a major clinical and public health challenge. Worldwide, CVD accounts for substantial morbidity and mortality. The major modifiable CVD risk factors are known and all of them cause endothelial activation and dysfunction. Preventing and controlling the established risk factors are associated with preserved endothelial function and reduced risk of CVD. Research advances that improve our understanding of strategies to preserve endothelial function or make the endothelial cells resilient to environmental insults may help improve our preventive interventions. This summary statement addresses the current state of the science with respect to endothelial dysfunction and CVD pathogenesis, diagnostic evaluation, and suggested strategies for public health practice and research.

Original languageEnglish (US)
Pages (from-to)318-320
Number of pages3
JournalVascular Pharmacology
Volume46
Issue number5 SPEC. ISS.
DOIs
StatePublished - Jan 1 2007

Fingerprint

Vascular Endothelium
Cardiovascular Diseases
Public Health Practice
Research
Myocardial Ischemia
Endothelial Cells
Public Health
Stroke
Morbidity
Mortality

Keywords

  • Cardiovascular
  • Endothelium
  • Prevention

ASJC Scopus subject areas

  • Physiology
  • Molecular Medicine
  • Pharmacology

Cite this

Mensah, G. A., Ryan, U. S., Hooper, W. C., Engelgau, M. M., Callow, A. D., Kapuku, K. G., & Mantovani, A. (2007). Vascular endothelium summary statement II: Cardiovascular disease prevention and control. Vascular Pharmacology, 46(5 SPEC. ISS.), 318-320. https://doi.org/10.1016/j.vph.2006.10.019

Vascular endothelium summary statement II : Cardiovascular disease prevention and control. / Mensah, George A.; Ryan, Una S.; Hooper, W. Craig; Engelgau, Michael M.; Callow, Allan D.; Kapuku, Kakota Gaston; Mantovani, Alberto.

In: Vascular Pharmacology, Vol. 46, No. 5 SPEC. ISS., 01.01.2007, p. 318-320.

Research output: Contribution to journalArticle

Mensah, GA, Ryan, US, Hooper, WC, Engelgau, MM, Callow, AD, Kapuku, KG & Mantovani, A 2007, 'Vascular endothelium summary statement II: Cardiovascular disease prevention and control', Vascular Pharmacology, vol. 46, no. 5 SPEC. ISS., pp. 318-320. https://doi.org/10.1016/j.vph.2006.10.019
Mensah, George A. ; Ryan, Una S. ; Hooper, W. Craig ; Engelgau, Michael M. ; Callow, Allan D. ; Kapuku, Kakota Gaston ; Mantovani, Alberto. / Vascular endothelium summary statement II : Cardiovascular disease prevention and control. In: Vascular Pharmacology. 2007 ; Vol. 46, No. 5 SPEC. ISS. pp. 318-320.
@article{fb776d785dd74e1dacdef1c49cbbec58,
title = "Vascular endothelium summary statement II: Cardiovascular disease prevention and control",
abstract = "The prevention and control of cardiovascular disease (CVD), principally ischemic heart disease and stroke, are a major clinical and public health challenge. Worldwide, CVD accounts for substantial morbidity and mortality. The major modifiable CVD risk factors are known and all of them cause endothelial activation and dysfunction. Preventing and controlling the established risk factors are associated with preserved endothelial function and reduced risk of CVD. Research advances that improve our understanding of strategies to preserve endothelial function or make the endothelial cells resilient to environmental insults may help improve our preventive interventions. This summary statement addresses the current state of the science with respect to endothelial dysfunction and CVD pathogenesis, diagnostic evaluation, and suggested strategies for public health practice and research.",
keywords = "Cardiovascular, Endothelium, Prevention",
author = "Mensah, {George A.} and Ryan, {Una S.} and Hooper, {W. Craig} and Engelgau, {Michael M.} and Callow, {Allan D.} and Kapuku, {Kakota Gaston} and Alberto Mantovani",
year = "2007",
month = "1",
day = "1",
doi = "10.1016/j.vph.2006.10.019",
language = "English (US)",
volume = "46",
pages = "318--320",
journal = "Vascular Pharmacology",
issn = "1537-1891",
publisher = "Elsevier Inc.",
number = "5 SPEC. ISS.",

}

TY - JOUR

T1 - Vascular endothelium summary statement II

T2 - Cardiovascular disease prevention and control

AU - Mensah, George A.

AU - Ryan, Una S.

AU - Hooper, W. Craig

AU - Engelgau, Michael M.

AU - Callow, Allan D.

AU - Kapuku, Kakota Gaston

AU - Mantovani, Alberto

PY - 2007/1/1

Y1 - 2007/1/1

N2 - The prevention and control of cardiovascular disease (CVD), principally ischemic heart disease and stroke, are a major clinical and public health challenge. Worldwide, CVD accounts for substantial morbidity and mortality. The major modifiable CVD risk factors are known and all of them cause endothelial activation and dysfunction. Preventing and controlling the established risk factors are associated with preserved endothelial function and reduced risk of CVD. Research advances that improve our understanding of strategies to preserve endothelial function or make the endothelial cells resilient to environmental insults may help improve our preventive interventions. This summary statement addresses the current state of the science with respect to endothelial dysfunction and CVD pathogenesis, diagnostic evaluation, and suggested strategies for public health practice and research.

AB - The prevention and control of cardiovascular disease (CVD), principally ischemic heart disease and stroke, are a major clinical and public health challenge. Worldwide, CVD accounts for substantial morbidity and mortality. The major modifiable CVD risk factors are known and all of them cause endothelial activation and dysfunction. Preventing and controlling the established risk factors are associated with preserved endothelial function and reduced risk of CVD. Research advances that improve our understanding of strategies to preserve endothelial function or make the endothelial cells resilient to environmental insults may help improve our preventive interventions. This summary statement addresses the current state of the science with respect to endothelial dysfunction and CVD pathogenesis, diagnostic evaluation, and suggested strategies for public health practice and research.

KW - Cardiovascular

KW - Endothelium

KW - Prevention

UR - http://www.scopus.com/inward/record.url?scp=33947158229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947158229&partnerID=8YFLogxK

U2 - 10.1016/j.vph.2006.10.019

DO - 10.1016/j.vph.2006.10.019

M3 - Article

C2 - 17229595

AN - SCOPUS:33947158229

VL - 46

SP - 318

EP - 320

JO - Vascular Pharmacology

JF - Vascular Pharmacology

SN - 1537-1891

IS - 5 SPEC. ISS.

ER -